The Effect of High Salt Intake on Betaine-Homocysteine S-Methyltransferase Expression in the Guinea Pig
Delgado-Reyes, Cassandra Veronica
This item is only available for download by members of the University of Illinois community. Students, faculty, and staff at the U of I may log in with your NetID and password to view the item. If you are trying to access an Illinois-restricted dissertation or thesis, you can request a copy through your library's Inter-Library Loan office or purchase a copy directly from ProQuest.
Permalink
https://hdl.handle.net/2142/84933
Description
Title
The Effect of High Salt Intake on Betaine-Homocysteine S-Methyltransferase Expression in the Guinea Pig
Author(s)
Delgado-Reyes, Cassandra Veronica
Issue Date
2003
Doctoral Committee Chair(s)
Garrow, Timothy A.
Department of Study
Nutritional Sciences
Discipline
Nutritional Sciences
Degree Granting Institution
University of Illinois at Urbana-Champaign
Degree Name
Ph.D.
Degree Level
Dissertation
Keyword(s)
Chemistry, Biochemistry
Language
eng
Abstract
BHMT is the only enzyme known to metabolize betaine, leading to the hypothesis that BHMT is down-regulated under conditions requiring the accumulation of betaine, such as high salt intake. BHMT is expressed in the livers of mammals and only a few species such as pig, guinea pig, and primates (including humans) have been shown to express BHMT in the kidney. Immunodetection methods were used to demonstrate that humans and guinea pigs have similar patterns of hepatic and renal BHMT expression and suggest that the guinea pig is a suitable in vivo model for studying renal BHMT. Guinea pig, however, also demonstrated BHMT expression in the pancreas. To investigate the possible osmotic regulation of BHMT, guinea pigs were subjected to high salt intake and BHMT expression analyzed. BHMT activity in liver and kidney cortex decreased approximately 55%, but no change in pancreatic BHMT activity was observed. Neither a soluble effector nor an increase in ionic strength had an effect on BHMT activity. Choline dehydrogenase, the enzyme responsible for the committed step in de novo synthesis of betaine, showed no change in liver or kidney cortex activity with treatment. Western blot analysis indicated a 30% reduction in steady-state liver and kidney cortex BHMT protein. Real-time PCR using TagMan chemistry demonstrated a 93% reduction in steady-state liver BHMT mRNA and a 72% reduction in steady-state kidney cortex BHMT mRNA. The discrepancy in the reduction of BHMT activity, steady-state protein, and steady-state mRNA may suggest complex regulation of BHMT expression including variable turnover rates of protein and mRNA and post-translational modifications of the BHMT enzyme.
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.
